2192
Porcari et al.
the cervix. A gynecologic oncology group studyAm. J. Clin. Oncol. 1993,
16, 506–508.
33. Kucera, L.S.; Iyer, N.P.; Puckett, S.H.; Buckheit, R.W., Jr.; Westbrook, L.;
Toyer, B.R.; White, E.L.; Germany-Decker, J.M.; Shannon, W.M.; Chen,
R.C.; Nassiri, M.R.; Shipman, C., Jr.; Townsend, L.B.; Drach, J.C. Activity
of triciribine and triciribine-50-monophosphate against human immunodefi-
ciency virus types 1 and 2. AIDS Res. Hum. Retroviruses 1993, 9, 307–314.
34. Ptak, R.G.; Borysko, K.Z.; Porcari, A.R.; Buthod, J.L.; Holland, L.E.;
Shipman, C., Jr.; Townsend, L.B.; Drach, J.C. Phosphorylation of triciribine
is necessary for activity against HIV-1. AIDS Res. Human Retroviruses 1998,
14, 1315–1322.
35. Townsend, L.B.; Kawasaki, A.M.; VanSickle, A.P.; Wotring, L.L. The synth-
esis and biological activity of certain pentaazaacenaphthylenes, hexaazaace-
naphthylenes and their corresponding nucleosides. Nucleic Acids Symp. Ser.
1986, 17, 41–44.
36. Kawasaki, A.M.; Townsend, L.B. An unusual reductive ring-opening of the
1,2,3,5,6,7-hexaazaacenaphthylene ring system. Tetrahedron Lett. 1989, 30,
3287–3290.
37. VanSickle, A.; Kawasaki, A.M.; Townsend, L.B. The Synthesis of 8-amino-6-
N-methyl-1,2,3,5,6,7-hexaazaacenaphthylene. Heterocycles 1990, 30, 963–969.
38. Kawasaki, A.M.; Wotring, L.L.; Townsend, L.B. Synthesis and cytotoxicity
studies of 8-amino-6-methyl-2-b-D-ribofuranosyl-1,2,3,5,6,7-hexaazaacenaph-
thylene (7-aza-TCN) and the corresponding 20-deoxy- and arabinonucleoside
analogues. J. Med. Chem. 1990, 33, 3170–3176.
39. Kawasaki, A.M.; Townsend, L.B. Synthesis of 8-amino-4-methylthio-6-methyl-
2-(b-D-ribofuranosyl)-2,6-dihydro-1,2,3,5,6,7-hexaazaacenaphthylene and an
unusual reductive ring-opening of the 1,2,3,5,6,7-hexaazaacenaphthylene ring
system. J. Heterocycl. Chem. 1991, 28, 1–5.
40. Porcari, A.R.; Borysko, K.Z.; Ptak, R.G.; Breitenbach, J.M.; Wotring, L.L.;
Drach, J.C.; Townsend, L.B. Acyclic sugar analogs of triciribine: Correlation
of antiviral and antineoplastic activity with intracellular phosphorylation.
Nucleosides & Nucleotides 1999, 18, 2475–2497.
41. Porcari, A.R.; Borysko, K.Z.; Ptak, R.G.; Breitenbach, J.M.; Vittori, S.;
Wotring, L.L.; Drach, J.C.; Townsend, L.B. Deoxy sugar analogs of triciribine:
Correlation of antiviral and antineoplastic activity with intracellular phosphor-
ylation. J. Med. Chem. 2000, 43, 2438–2448.
42. Swayze, E.E.; Hinkley, J.M.; Townsend, L.B. The improved preparation of a
versatile synthon for the synthesis of pyrrolo[2,3-d]pyrimidines. In Nucleic Acid
Chemistry; Townsend, L.B., Tipson, R.S., Eds.; Wiley-Interscience: New York,
1991; Vol. 4, 16–17.
43. Cheng, C.S.; Hinshaw, B.C.; Panzica, R.P.; Townsend, L.B. Synthesis of 2-
amino-5-cyano-7-(b-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-4-one. An impor-
tant precursor for the synthesis of nucleoside Q and Q0. J. Am. Chem. Soc.
1976, 98, 7870–7872.
44. Turk, S.R.; Shipman, C., Jr.; Nassiri, M.R.; Genzlinger, G.; Krawczyk, S.H.;
Townsend, L.B.; Drach, J.C. Pyrrolo[2,3-d]pyrimidine nucleosides as inhibitors
of human cytomegalovirus. Antimicrob. Agents Chemother. 1987, 31, 544–550.